Biographical summary
Barbara Tylka, O.D., F.A.A.O., is a board-certified optometrist at Mayo Clinic in Rochester, Minnesota, specializing in complex dry eye disease and ocular surface disorders. She founded the Mayo Clinic Dry Eye Clinic, developing a comprehensive approach that combines advanced diagnostic evaluation, medical therapy, office-based procedures, and multidisciplinary care for patients with persistent or complex ocular surface disease.
Dr. Tylka's clinical expertise includes dry eye disease, meibomian gland dysfunction, blepharitis, ocular rosacea, corneal disease, and ocular surface complications associated with systemic and autoimmune conditions. She works closely with colleagues across Mayo Clinic, including Rheumatology, Hematology, the Sjögren's Clinic, Cornea, and the scleral lens team, to coordinate care for patients whose ocular surface disease requires multidisciplinary evaluation and management.
Through the Mayo Clinic Dry Eye Clinic, Dr. Tylka has expanded access to specialized ocular surface treatments, including intense pulsed light (IPL) therapy, thermal meibomian gland expression, microblepharoexfoliation, punctal occlusion, and amniotic membrane therapy. Her approach emphasizes identifying the underlying contributors to ocular surface disease and developing individualized treatment strategies for patients who may not have responded adequately to conventional therapy.
Dr. Tylka is actively involved in clinical education, research, quality improvement, and guideline development at Mayo Clinic. She mentors residents and clinicians in evidence-based eye care and presents her work at national professional meetings. Her professional interests include emerging dry eye therapies, procedural management of ocular surface disease, clinical outcomes, and development of multidisciplinary models of care for patients with complex dry eye disease.
Clinical interests and conditions treated
- Complex and refractory dry eye disease
- Meibomian gland dysfunction
- Blepharitis
- Ocular rosacea
- Sjögren's and autoimmune-associated ocular surface disease
- Corneal and ocular surface disorders
- Perioperative ocular surface optimization
Specialized procedures and treatments
- Intense pulsed light (IPL) therapy
- Thermal meibomian gland expression
- Microblepharoexfoliation
- Punctal occlusion
- Amniotic membrane therapy
- Advanced medical management of dry eye and ocular surface disease
- Coordination of scleral lens evaluation when indicated
- Multidisciplinary referral and collaborative care
Conditions treated
Mayo Clinic locations
Education
- 2016
Associate Resident - Ocular Disease and Primary Care Veterans Administration
- 2015
OD - Doctor of Optometry Illinois College of Optometry
- 2011
Bachelor - Molecular & Cellular Biology University of Illinois at Urbana-Champaign
Activities and honors
Certifications
- 2021
OptometryAmerican Board of Optometry
Awards and honors
- 2015
Magna Cum LaudeIllinois College of Optometry
Professional memberships
- 2026 - present
MemberDry Eye Society of the Americas
- 2023 - present
Board MemberMinnesota Optometric Association
- 2014 - present
MemberThe Association for Research in Vision and Ophthalmology
- 2011 - present
MemberAmerican Optometric Association
- 2011 - present
MemberAmerican Academy of Optometry
Publications